| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |